Athanasios Papagelis
Angel Investor
Athens, Greece
Athanasios Papagelis is a seed investor in Athens focused on EdTech and Medical. Thanos Papangelis is the Co-Founder & Product Innovation Advisor at Epignosis.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Athanasios Papagelis invests in
Stages Athanasios Papagelis invests in
Countries Athanasios Papagelis invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $412k–$4.5M
Investment Focus
Industry
- EdTech 1 (33%)
- Medical 1 (33%)
- Software 1 (33%)
- Training 1 (33%)
- Education 1 (33%)
Stage
- Seed 1 (33%)
- Pre-Seed 1 (33%)
Country
- Switzerland 1 (33%)
- United Kingdom 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ORamaVR (www.oramavr.com) is a deep technology, spatial computing startup, innovating the field of med-ed-tech Virtual Reality (VR) training simulation authoring platforms. Our technologies are based on state-of-the-art research by world-renowned scientists team members. This research is turned into a novel, symbiotic VR authoring and simulationplatform by our top engineers, medical professionals and business developers. ORamaVR was founded in 2016 and received initial €575K pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. The company has moved its HQ to Geneva, Switzerland upon strategic partners' demand. ORamaVR is adopted by the USC Keck School of Medicine, Los Angeles, NYU Langone Medical centre in New York, the University of Geneva and the Inselspital Hospital system in Switzerland, FORTH and the University of Athens in Greece and recently Western Governors University, Fayetteville State University and the University of Michigan in USA. Medacta International, a leading Swiss medical implant manufacturer expressed high interest to collaborate intensively with ORamaVR. ORamaVR has been awarded in 2020 an Epic Games Mega-Grant, in 2019 the Augmented World Expo (AWE) Auggie award for "Best Societal Impact” and the prestigious FARE award, from the American Association of Hip and Knee Surgeons (AAHKS) in 2018. ORamaVR has attracted more than €1.3M in R&D grants and awards up to date. In 2020 ORamaVR concluded a €370K bridge round led by HTC Vive, a leader in enterprise virtual reality. | $4.5M / Seed / Jan 27, 2026 | ||
| Morphoses is an edtech company that is changing the way kids learn and develop their employability skills. Our innovative end-to-end solution engages and educates learners aged 6-17 in a fun and efficient manner through weekly 1hr live sessions in collaborative groups led by top-notch tutors specialized in soft skills.The offering is currentlyavailable to medium-large companies as a way to provide a valuable benefit to parent employees, as well as through educational institutions to expand their range of tutoring and offerings. | $2.3M / Pre-Seed / Sep 27, 2023 | ||
| ORamaVR (www.oramavr.com) is a deep technology, spatial computing startup, innovating the field of med-ed-tech Virtual Reality (VR) training simulation authoring platforms. Our technologies are based on state-of-the-art research by world-renowned scientists team members. This research is turned into a novel, symbiotic VR authoring and simulationplatform by our top engineers, medical professionals and business developers. ORamaVR was founded in 2016 and received initial €575K pre-seed financing from the VC PJ TECH CATALYST FUND in Greece. The company has moved its HQ to Geneva, Switzerland upon strategic partners' demand. ORamaVR is adopted by the USC Keck School of Medicine, Los Angeles, NYU Langone Medical centre in New York, the University of Geneva and the Inselspital Hospital system in Switzerland, FORTH and the University of Athens in Greece and recently Western Governors University, Fayetteville State University and the University of Michigan in USA. Medacta International, a leading Swiss medical implant manufacturer expressed high interest to collaborate intensively with ORamaVR. ORamaVR has been awarded in 2020 an Epic Games Mega-Grant, in 2019 the Augmented World Expo (AWE) Auggie award for "Best Societal Impact” and the prestigious FARE award, from the American Association of Hip and Knee Surgeons (AAHKS) in 2018. ORamaVR has attracted more than €1.3M in R&D grants and awards up to date. In 2020 ORamaVR concluded a €370K bridge round led by HTC Vive, a leader in enterprise virtual reality. | $412.1K / Seed / Oct 30, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Athanasios Papagelis invest in?
Athanasios Papagelis invests primarily in EdTech, Medical and Software startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Athanasios Papagelis invest in?
Athanasios Papagelis typically joins rounds of $412k–$4.5M at Seed. These are whole funding-round sizes, not Athanasios Papagelis's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Athanasios Papagelis took part in.
How do I contact Athanasios Papagelis?
Public channels for Athanasios Papagelis include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Athanasios Papagelis last invest?
The most recent investment recorded for Athanasios Papagelis closed in Jan 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
